Patents by Inventor Barbara Proksch

Barbara Proksch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell selection method and cells obtained therefrom
    Patent number: 9599616
    Abstract: The present invention relates to a method for the in vitro selection of at least one therapeutic cell subpopulation from an original cell population of eukaryotic cells, as well as to the therapeutic cell subpopulation selected by the method, which can be used for the treatment of diseases of tissues or organs. The selected cells are highly migrative and the method according to the invention provides for the selection of these highly migrative subpopulations from a sample comprising a mixture of cells.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: March 21, 2017
    Assignee: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
    Inventors: Lusine Danielyan, Gayane Buniatian, Matthias Schwab, Christoph Hermann Gleiter, Barbara Proksch, Richard Schäfer
  • Cell selection method and cells obtained therefrom
    Publication number: 20160252508
    Abstract: The present invention relates to a method for the in vitro selection of at least one therapeutic cell subpopulation from an original cell population of eukaryotic cells, as well as to the therapeutic cell subpopulation selected by the method, which can be used for the treatment of diseases of tissues or organs. The selected cells are highly migrative and the method according to the invention provides for the selection of these highly migrative subpopulations from a sample comprising a mixture of cells.
    Type: Application
    Filed: February 27, 2015
    Publication date: September 1, 2016
    Inventors: Lusine Danielyan, Gayane Buniatian, Matthias Schwab, Christoph Hermann Gleiter, Barbara Proksch, Richard Schäfer
  • Use of the opposite cell differentiation program (OCDP) for the treatment of degenerated organs in the pathological state
    Patent number: 9157065
    Abstract: The present invention relates to a method for the treatment of organs which are degenerative and/or in the pathological state by means of the use of cells, which are phenotypically stably differentiating or differentiated but not necessarily ultimately predetermined with respect to development, from a donor organ selected according to the principles of the opposite cell differentiation program (OCDP) and also to the use of cells of this type for the treatment or for the production of a drug for treatment of the same. Furthermore, the present invention relates to pharmaceutical agents comprising suitable phenotypically stable cells, cells of a first organ which is different from the second organ with respect to organ type thereby being used, which, in the normal physiological state with respect to a predetermined set of expressed genes and/or phenotypical properties, have opposite properties to the second cells in the normal physiological state.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: October 13, 2015
    Assignee: Universitat Leipzig
    Inventors: Gayane Buniatian, Rolf Gebhardt, Christoph Gleiter, Lusine Danielyan, Barbara Proksch
  • USE OF THE OPPOSITE CELL DIFFERENTIATION PROGRAM (OCDP) FOR THE TREATMENT OF DEGENERATED ORGANS IN THE PATHOLOGICAL STATE
    Publication number: 20100278786
    Abstract: The present invention relates to a method for the treatment of organs which are degenerative and/or in the pathological state by means of the use of cells, which are phenotypically stably differentiating or differentiated but not necessarily ultimately predetermined with respect to development, from a donor organ selected according to the principles of the opposite cell differentiation program (OCDP) and also to the use of cells of this type for the treatment or for the production of a drug for treatment of the same. Furthermore, the present invention relates to pharmaceutical agents comprising suitable phenotypically stable cells, cells of a first organ which is different from the second organ with respect to organ type thereby being used, which, in the normal physiological state with respect to a predetermined set of expressed genes and/or phenotypical properties, have opposite properties to the second cells in the normal physiological state.
    Type: Application
    Filed: April 18, 2008
    Publication date: November 4, 2010
    Applicant: Universitat Leipzig
    Inventors: Gayane Buniatian, Rolf Gebhardt, Christoph Gleiter, Lusine Danielyan, Barbara Proksch